ACH
PMVP icon

ArrowMark Colorado Holdings’s PMV Pharmaceuticals PMVP Stock Holding History

ArrowMark Colorado Holdings’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63M Sell
1,959,579
-913,185
-32% -$1.17M 0.11% 216
2026
Q1 		$3.56M Sell
2,872,764
-217,329
-7% -$276K 0.09% 193
2025
Q4 		$3.86M Sell
3,090,093
-211,248
-6% -$283K 0.09% 210
2025
Q3 		$4.62M Buy
3,301,341
+113,225
+4% +$157K 0.09% 198
2025
Q2 		$3.38M Sell
3,188,116
-120,561
-4% -$118K 0.06% 208
2025
Q1 		$3.61M Sell
3,308,677
-199,774
-6% -$271K 0.06% 200
2024
Q4 		$5.3M Sell
3,508,451
-138,840
-4% -$220K 0.07% 188
2024
Q3 		$5.43M Buy
3,647,291
+842,509
+30% +$1.3M 0.07% 184
2024
Q2 		$4.54M Sell
2,804,782
-393,974
-12% -$711K 0.05% 209
2024
Q1 		$5.44M Buy
3,198,756
+484,613
+18% +$905K 0.06% 207
2023
Q4 		$8.41M Buy
2,714,143
+2,443,717
+904% +$6.47M 0.09% 159
2023
Q3 		$1.66M Hold
270,426
– – 0.02% 243
2023
Q2 		$1.69M Sell
270,426
-629,135
-70% -$3.3M 0.02% 234
2023
Q1 		$4.29M Sell
899,561
-65,424
-7% -$460K 0.05% 205
2022
Q4 		$8.4M Buy
964,985
+85,523
+10% +$912K 0.1% 173
2022
Q3 		$10.5M Buy
879,462
+47,996
+6% +$693K 0.13% 144
2022
Q2 		$11.8M Buy
831,466
+263,117
+46% +$3.83M 0.14% 143
2022
Q1 		$11.8M Buy
568,349
+25,044
+5% +$442K 0.1% 166
2021
Q4 		$12.6M Buy
543,305
+15,885
+3% +$384K 0.1% 171
2021
Q3 		$15.7M Buy
527,420
+94,292
+22% +$3.01M 0.12% 145
2021
Q2 		$14.8M Buy
433,128
+38,065
+10% +$1.27M 0.11% 156
2021
Q1 		$13M Buy
395,063
+2,455
+0.6% +$96.8K 0.1% 165
2020
Q4 		$24.1M Sell
392,608
-7,392
-2% -$290K 0.19% 113
2020
Q3 		$14.2M Buy
+400,000
New +$14.7M 0.14% 123

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ArrowMark Colorado Holdings's PMVP Position: Q2 2026 in Review

ArrowMark Colorado Holdings reduced its PMV Pharmaceuticals (PMVP) stake by 32% in Q2 2026, selling an estimated $1.17M and leaving 1,959,579 shares worth $2.63M. The position accounts for 0.11% of the portfolio, ranked #216.

ArrowMark Colorado Holdings first reported a position in PMVP in Q3 2020 and has held it in 24 quarters since. The position peaked at $24.1M in Q4 2020. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • ArrowMark Colorado Holdings held 1,959,579 shares of PMV Pharmaceuticals worth $2.63M as of Q2 2026.
  • ArrowMark Colorado Holdings sold 913,185 PMV Pharmaceuticals shares in Q2 2026, an estimated $1.17M.
  • PMV Pharmaceuticals made up 0.11% of ArrowMark Colorado Holdings's portfolio in Q2 2026, its #216 holding.
  • ArrowMark Colorado Holdings first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • ArrowMark Colorado Holdings's PMV Pharmaceuticals position peaked at $24.1M in Q4 2020.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.